CYP19A1 and endometrial cancer: None of the published studies have attempted a systematic assessment of all common CYP19A1 variants in order to determine i) which are most likely to be causal for endometrial cancer and/or E2 concentration, ii) whether multiple independent causal variants exist at this locus for either trait, and iii) whether the same variant or variants are responsible for both traits.